financetom
Business
financetom
/
Business
/
Trump administration directs Sable Offshore to restore Santa Ynez oil unit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump administration directs Sable Offshore to restore Santa Ynez oil unit
Mar 13, 2026 6:23 PM

LOS ANGELES, March 13 (Reuters) - The Trump

administration on Friday directed Sable Offshore ( SOC ) to

restore oil drilling operations off the southern California

coast, the U.S. Energy Department said.

The move aims to restart oil production at a cluster of

offshore platforms as fuel prices continue to rise in the wake

of the war on Iran. President Donald Trump on Friday signed an

executive order to let the secretary of energy take actions

under the Defense Production Act.

U.S. Secretary of Energy Chris Wright told Sable to restart

work at the Santa Ynez unit and Santa Ynez pipeline "to address

supply disruption risks caused by California policies that have

left the region and U.S. military forces dependent on foreign

oil," the Energy Department said in a statement.

Sable Offshore ( SOC ) did not immediately respond to a request for

comment.

The Santa Ynez unit and Santa Ynez pipeline system have been

points of contention in California. The Santa Ynez offshore

platforms were shut down in 2015 after an oil spill, but the

company has since restarted production at one of them.

A state judge last year ruled against the Houston,

Texas-based company's request to lift a cease and desist order

on repairs it had made to an onshore pipeline system.

In January, the California attorney general said the state

was suing the Trump administration for asserting federal

authority over two state pipelines and permitting Sable to

restart pumping oil through them.

The Energy Department said Sable's facility could produce

approximately 50,000 barrels of oil per day.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Urban Edge Properties' Q1 Adjusted FFO, Revenue Rise; 2024 Adjusted FFO Guidance Lifted
Urban Edge Properties' Q1 Adjusted FFO, Revenue Rise; 2024 Adjusted FFO Guidance Lifted
May 7, 2024
09:12 AM EDT, 05/07/2024 (MT Newswires) -- Urban Edge Properties ( UE ) reported Q1 adjusted funds from operations Tuesday of $0.33 per diluted share, up from $0.32 a year earlier. Two analysts polled by Capital IQ expected $0.23. Total revenue for the quarter ended March 31 was $109.6 million, up from $99.4 million a year earlier. A sole analyst...
Froot Loops maker WK Kellogg beats revenue estimates on higher prices
Froot Loops maker WK Kellogg beats revenue estimates on higher prices
May 7, 2024
May 7 (Reuters) - WK Kellogg Co ( KLG ) beat Wall Street estimates for quarterly sales on Tuesday, as higher product prices offset pressure from slowing demand for the Froot Loops maker's ready-to-eat breakfast items and snacks. Like other major brands in the packaged food market, the spun-off North American cereal business of Kellanova ( K ) has been...
Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday
Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday
May 7, 2024
09:12 AM EDT, 05/07/2024 (MT Newswires) -- Consumer stocks were mixed pre-bell Tuesday as the Consumer Discretionary Select Sector SPDR Fund ( XLY ) was down 0.3% and the Consumer Staples Select Sector SPDR Fund ( XLP ) was up 0.2% recently. Hims & Hers Health ( HIMS ) advanced by over 13% after reporting that it swung to Q1...
Future Pak increases buyout offer for Vanda Pharmaceuticals
Future Pak increases buyout offer for Vanda Pharmaceuticals
May 7, 2024
May 7 (Reuters) - Privately held contract manufacture Future Pak said on Tuesday it will include contingent value rights as part of its buyout offer of Vanda Pharmaceuticals ( VNDA ) , in addition to its proposed cash offer price of $7.25 to $7.75 per share for the drugmaker. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved